Design and synthesis of 4-amino-2′,4′-dihydroxyindanone derivatives as potent inhibitors of tyrosinase and melanin biosynthesis in human melanoma cells

Leticia M. Lazinski,Morane Beaumet,Brayan Roulier,Rémy Gay,Guy Royal,Marc Maresca,Romain Haudecoeur
DOI: https://doi.org/10.1016/j.ejmech.2024.116165
IF: 7.088
2024-01-22
European Journal of Medicinal Chemistry
Abstract:Melanogenesis inhibition constitutes a privileged therapeutic solution to treat skin hyperpigmentation, a major dermatological concern associated with the overproduction of melanin by human tyrosinase ( hs TYR). Despite the existence of many well-known TYR (tyrosinase) inhibitors commercialized in skin formulations, their hs TYR-inhibition efficacy remains poor since most of them were investigated over mushroom tyrosinase ( ab TYR), a model with low homology relative to hs TYR. Considering the need for new potent hs TYR inhibitors, we designed and synthesized a series of indanones starting from 4-hydroxy compound 1a , one of the two most active derivatives reported to date against the human enzyme, together with marketed thiamidol. We observed that analogues featuring 4-amino and 4-amido-2′,4′-dihydroxyindanone motifs showed two-to ten-fold increase in activity over human melanoma MNT-1 cell lysates, and a ten-fold improvement in a 4-days whole-cell experiment, compared to parent analogue 1a . Molecular docking investigation was performed for the most promising 4-amido derivatives and suggested a plausible interaction pattern with the second coordination sphere of hs TYR, notably through hydrogen bonding with Glu203, confirming their impact in the binding mode with hs TYR active site.
chemistry, medicinal
What problem does this paper attempt to address?